Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
59.29
+1.04 (1.79%)
At close: Mar 6, 2026, 4:00 PM EST
59.99
+0.70 (1.18%)
After-hours: Mar 6, 2026, 7:49 PM EST
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $8.53 billion as of March 6, 2026. Its market cap has decreased by -16.98% in one year.
Market Cap
8.53B
Enterprise Value
7.09B
1-Year Change
-16.98%
Ranking
Category
Stock Price
$59.29
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $8.53B, an increase of 518.35%. That is a compound annual growth rate of 37.46%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmunityBio | 10.28B |
| Madrigal Pharmaceuticals | 9.77B |
| Arrowhead Pharmaceuticals | 8.98B |
| Bio-Techne | 8.92B |
| Praxis Precision Medicines | 8.86B |
| ABIVAX Société Anonyme | 8.61B |
| Axsome Therapeutics | 8.39B |
| Halozyme Therapeutics | 8.19B |